Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eurofins Scientific SEERFSF -3.59%79 Intrinsic Value: Projected FCF is $69.44 as of Aug. 25, 2026. GuruFocus rates ERFSF with a GF Score™ of 79/100 and a GF Value™ of $75.74 (Fairly Valued). The stock has 7 warning signs investors should review. Among 106 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 61.32% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Eurofins Scientific SE's Intrinsic Value: Projected FCF or its related term are showing as below:
ERFSF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.8 Med: 1.71 Max: 2.66
Current: 1.2
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Eurofins Scientific SE was 2.66. The lowest was 0.80. And the median was 1.71.
ERFSF's Price-to-Projected-FCF is ranked better than 61.32% of 106
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.52
vs ERFSF: 1.20
Eurofins Scientific SE (OTCPK:ERFSF) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Eurofins Scientific SE's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
83.50
/
65.094349372524
=
1.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Intrinsic Value: Projected FCF Related Terms
Eurofins Scientific SE Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Intrinsic Value: Projected FCF Chart
ERFSF vs TMO, DHR, IDXX: Intrinsic Value: Projected FCF Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Price-to-Projected-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Price-to-Projected-FCF falls into.
Eurofins Scientific SE Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $69.44 mean?
Eurofins Scientific SE (ERFSF) has a Intrinsic Value: Projected FCF of $69.44 as of Aug. 25, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Eurofins Scientific SE and its competitors. According to the industry distribution chart, Eurofins Scientific SE ranks #41 out of 106 companies in the Medical Diagnostics & Research industry, placing it in the top 38.7%.
Is Eurofins Scientific SE's Intrinsic Value: Projected FCF too high?
Eurofins Scientific SE's current Intrinsic Value: Projected FCF is $69.44. The Medical Diagnostics & Research industry median Intrinsic Value: Projected FCF is 1.52. Eurofins Scientific SE's value of $69.44 is 4468.4% above this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #41 out of 106 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Intrinsic Value: Projected FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #41 out of 106 companies for Intrinsic Value: Projected FCF. This puts Eurofins Scientific SE in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.52. Eurofins Scientific SE's value of $69.44 is 4468.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Medical Diagnostics & Research company?
The median Intrinsic Value: Projected FCF among Medical Diagnostics & Research companies is 1.52, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Intrinsic Value: Projected FCF of $69.44 is 4468.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Intrinsic Value: Projected FCF is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Intrinsic Value: Projected FCF is $69.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $75.74, compared to a current price of $83.50 — trading 10.2% above its estimated fair value. The current Intrinsic Value: Projected FCF is $69.44 and 4468.4% above the Medical Diagnostics & Research industry median of 1.52. Eurofins Scientific SE's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Intrinsic Value: Projected FCF is $69.44 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $83.50 is trading 10.2% above its estimated GF Value™ of $75.74.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Intrinsic Value: Projected FCF: $69.44
GF Value™: $75.74 vs. price of $83.50 (10.2% above fair value)
Industry Position: 4468.4% above the Medical Diagnostics & Research median (#41 of 106)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
79GF Score
Get the complete analysis for ERFSF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
